Drug General Information
Drug ID	D0Y0BB
Former ID	DNC014148
Drug Name	3-(4-Chlorophenyl)-2-nortropene
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530502]
Structure		Download 2D MOL 3D MOL
Formula	C13H14ClN
Canonical SMILES	C1CC2C=C(CC1N2)C3=CC=C(C=C3)Cl
InChI	1S/C13H14ClN/c14-11-3-1-9(2-4-11)10-7-12-5-6-13(8-10)15-12/h1-4,7,12-13,15H,5-6,8H2
InChIKey	QBSBBGLHCMPGNO-UHFFFAOYSA-N
PubChem Compound ID	9859279
Target and Pathway
Target(s)	Sodium-dependent serotonin transporter	Target Info	Inhibitor	[530502]
	Sodium-dependent dopamine transporter	Target Info	Inhibitor	[530502]
KEGG Pathway	Serotonergic synapsehsa04728:Dopaminergic synapse
	Parkinson's disease
	Cocaine addiction
	Amphetamine addiction
	Alcoholism
NetPath Pathway	TCR Signaling Pathway
PANTHER Pathway	5HT1 type receptor mediated signaling pathway
	5HT2 type receptor mediated signaling pathway
	5HT3 type receptor mediated signaling pathway
	5HT4 type receptor mediated signaling pathwayP00001:Adrenaline and noradrenaline biosynthesis
	Parkinson disease
	Dopamine receptor mediated signaling pathway
Pathway Interaction Database	Alpha-synuclein signaling
Reactome	Na+/Cl- dependent neurotransmitter transporters
WikiPathways	Monoamine Transport
	SIDS Susceptibility Pathways
	NRF2 pathway
	Synaptic Vesicle Pathway
	Serotonin Transporter ActivityWP727:Monoamine Transport
	Dopaminergic Neurogenesis
	Parkinsons Disease Pathway
	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
	Neurotransmitter Clearance In The Synaptic Cleft
References
Ref 530502	Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8. Epub 2009 Oct 23.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.
Ref 530502	Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8. Epub 2009 Oct 23.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.